Eden Research (LON:EDEN) Trading Down 3.3% – Here’s Why

Eden Research plc (LON:EDEN) shares fell 3.3% on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares were traded during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 3.3 %

The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80. The company has a market cap of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The stock’s fifty day moving average is GBX 3.87 and its two-hundred day moving average is GBX 3.95.

Insider Buying and Selling

In other news, insider Alexander John Abrey acquired 540,540 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,362.19). Also, insider Lykele van der Broek bought 256,000 shares of Eden Research stock in a transaction dated Thursday, February 6th. The shares were bought at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,958.74). 14.02% of the stock is currently owned by company insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.